Requirement for deoxycytidine kinase in T and B lymphocyte development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 12, 2010, Pages 5551-5556

  Toy, Gerald ^a   Austin, Wayne R ^a   Liao, Hsiang I ^a   Cheng, Donghui ^a   Singh, Arun ^a   Campbell, Dean O ^a   Ishikawa, Tomo O ^a   Lehmann, Lynn W ^a   Satyamurthy, Nagichettiar ^a   Phelps, Michael E ^a   Herschman, Harvey R ^a   Czernin, Johannes ^a   Witte, Owen N ^a   Radu, Caius G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Combined immunodeficiency; Deoxyribonucleoside salvage; dNTP metabolism; Immune development; T and B lymphocytes

Indexed keywords

DEOXYCYTIDINE KINASE; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; NUCLEOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOPOIESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SOMATIC CELL; T LYMPHOCYTE; THYMUS; WILD TYPE;

ANIMALS; B-LYMPHOCYTES; DEOXYCYTIDINE KINASE; EXONS; GENE TARGETING; LYMPHOID TISSUE; LYMPHOPOIESIS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; T-LYMPHOCYTES;

MUS;

EID: 77950382095     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913900107     Document Type: Article

References (34)

1. Nyhan WL (2005) Disorders of purine and pyrimidine metabolism. Mol Genet Metab 86:25-33.
2. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067-1069.
3. Giblett ER (1985) ADA and PNP deficiencies: how it all began. Ann N Y Acad Sci 451:1-8.
4. Reichard P (1988) Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem 57:349-374.
5. Thelander L, Reichard P (1979) Reduction of ribonucleotides. Annu Rev Biochem 48:133-158.
6. Cohen A, Barankiewicz J, Lederman HM, Gelfand EW (1983) Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem 258:12334-12340.
7. Eriksson S, Munch-Petersen B, Johansson K, Eklund H (2002) Structure and function of cellular deoxyribonucleoside kinases. Cell Mol Life Sci 59:1327-1346.
8. Staub M, Spasokukotskaja T, Benczur M, Antoni F (1988) DNA synthesis and nucleoside metabolism in human tonsillar lymphocyte subpopulations. Acta Otolaryngol Suppl 454:118-124.
9. Staub M, Eriksson S (2006) The role of deoxycytidine kinase in DNA synthesis and nucleoside analog synthesis. Cancer Drug Discovery and Development: Deoxynucleoside Analogs in Cancer Therapy, ed Peters GJ (Humana, Totowa, NJ), pp 29-52.
10. Nicander B, Reichard P (1985) Evidence for the involvement of substrate cycles in the regulation of deoxyribonucleoside triphosphate pools in 3T6 cells. J Biol Chem 260:9216-9222.
11. Bianchi V, Pontis E, Reichard P (1987) Regulation of pyrimidine deoxyribonucleotide metabolism by substrate cycles in dCMP deaminase-deficient V79 hamster cells. Mol Cell Biol 7:4218-4224.
12. Bianchi V, Pontis E, Reichard P (1986) Interrelations between substrate cycles and de novo synthesis of pyrimidine deoxyribonucleoside triphosphates in 3T6 cells. Proc Natl Acad Sci USA 83:986-990.
13. Höglund L, Pontis E, Reichard P (1988) Effects of deoxycytidine and thymidine kinase deficiency on substrate cycles between deoxyribonucleosides and their 5′-phosphates. Cancer Res 48:3681-3687.
14. Bianchi V, Ferraro P, Borella S, Bonvini P, Reichard P (1994) Effects of mutational loss of nucleoside kinases on deoxyadenosine 5′-phosphate/ deoxyadenosine substrate cycle in cultured CEM and V79 cells. J Biol Chem 269:16677-16683. (Pubitemid 24200425)
15. Carson DA, Kaye J, Seegmiller JE (1977) Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci USA 74:5677-5681.
16. Carson DA, Kaye J, Wasson DB (1981) The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts. J Immunol 126:348-352.
17. 18F]-labeled 2′-deoxycytidine analog. Nat Med 14:783-788.
18. Laing RE, et al. (2009) Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography. Proc Natl Acad Sci USA 106:2847-2852.
19. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K (1991) Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 173:1213-1225.
20. Van Epps HL (2006) Bringing order to early B cell chaos. J Exp Med 203:1389.
21. Ciofani M, Zúñiga-Pflücker JC (2007) The thymus as an inductive site for T lymphopoiesis. Annu Rev Cell Dev Biol 23:463-493.
22. Macallan DC, et al. (1998) Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc Natl Acad Sci USA 95:708-713.
23. Neese RA, et al. (2002) Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci USA 99:15345-15350.
24. Busch R, Neese RA, Awada M, Hayes GM, Hellerstein MK (2007) Measurement of cell proliferation by heavy water labeling. Nat Protoc 2:3045-3057.
25. Herzog S, Reth M, Jumaa H (2009) Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 9:195-205.
26. Falk I, Biro J, Kohler H, Eichmann K (1996) Proliferation kinetics associated with T cell receptor-beta chain selection of fetal murine thymocytes. J Exp Med 184:2327-2339. (Pubitemid 27023732)
27. Hogquist KA, Baldwin TA, Jameson SC (2005) Central tolerance: learning self-control in the thymus. Nat Rev Immunol 5:772-782.
28. Penaloza C, Lin L, Lockshin RA, Zakeri Z (2006) Cell death in development: shaping the embryo. Histochem Cell Biol 126:149-158.
29. Bassing CH, Swat W, Alt FW (2002) The mechanism and regulation of chromosomal V(D)J recombination. Cell 109 (Suppl):S45-S55.
30. Joachims ML, et al. (2008) Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases. J Immunol 181:8153-8161.
31. Dobrovolsky VN, Bucci T, Heflich RH, Desjardins J, Richardson FC (2003) Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease. Mol Genet Metab 78:1-10. (Pubitemid 36268736)
32. Sicinska E, et al. (2003) Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4:451-461. (Pubitemid 38050042)
33. Cooper AB, et al. (2006) A unique function for cyclin D3 in early B cell development. Nat Immunol 7:489-497.
34. Liu P, Jenkins NA, Copeland NG (2003) A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 13:476-484. (Pubitemid 36395405)